Inactive and active state structures template selective tools for the human 5-HT5A receptor

被引:0
|
作者
Shicheng Zhang
He Chen
Chengwei Zhang
Ying Yang
Petr Popov
Jing Liu
Brian E. Krumm
Can Cao
Kuglae Kim
Yan Xiong
Vsevolod Katritch
Brian K. Shoichet
Jian Jin
Jonathan F. Fay
Bryan L. Roth
机构
[1] University of North Carolina at Chapel Hill,Department of Pharmacology, School of Medicine
[2] Tisch Cancer Institute,Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience
[3] Icahn School of Medicine at Mount Sinai,Department of Pharmaceutical Sciences
[4] University of California San Francisco,Departments of Quantitative and Computational Biology and Chemistry, Bridge Institute, USC Michelson Center for Convergent Biosciences
[5] School of Medicine,Department of Biochemistry and Biophysics
[6] iMolecule,undefined
[7] Skolkovo Institute of Science and Technology,undefined
[8] University of Southern California,undefined
[9] University of North Carolina at Chapel Hill School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Serotonin receptors are important targets for established therapeutics and drug development as they are expressed throughout the human body and play key roles in cell signaling. There are 12 serotonergic G protein-coupled receptor members encoded in the human genome, of which the 5-hydroxytryptamine (5-HT)5A receptor (5-HT5AR) is the least understood and lacks selective tool compounds. Here, we report four high-resolution (2.73–2.80 Å) structures of human 5-HT5ARs, including an inactive state structure bound to an antagonist AS2674723 by crystallization and active state structures bound to a partial agonist lisuride and two full agonists, 5-carboxamidotryptamine (5-CT) and methylergometrine, by cryo-EM. Leveraging the new structures, we developed a highly selective and potent antagonist for 5-HT5AR. Collectively, these findings both enhance our understanding of this enigmatic receptor and provide a roadmap for structure-based drug discovery for 5-HT5AR.
引用
收藏
页码:677 / 687
页数:10
相关论文
共 50 条
  • [41] Increased exploratory activity and altered response to LSD in mice lacking the 5-HT5A receptor
    Grailhe, R
    Waeber, C
    Dulawa, SC
    Hornung, JP
    Zhuang, XX
    Brunner, D
    Geyer, MA
    Hen, R
    NEURON, 1999, 22 (03) : 581 - 591
  • [42] Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands:: Structure-activity relationship elucidation
    Peters, Jens-Uwe
    Luebbers, Thomas
    Alanine, Alexander
    Kolczewski, Sabine
    Blasco, Francesca
    Steward, Lucinda
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 256 - 261
  • [43] Discovery of ASP5736, a novel 5-HT5A receptor antagonist as an antipsychotic drug
    Hamaguchi, Wataru
    Kinoyama, Isao
    Miyazaki, Takehiro
    Koganemaru, Yohei
    Washio, Takuya
    Kaneko, Osamu
    Kawamoto, Yuichiro
    Yamazaki, Mayako
    Fujii, Masahiro
    Hattori, Kouji
    Watanabe, Toshihiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [44] Association between allelic variation in the human 5-HT5A receptor gene and schizophrenia and affective disorder but not to clozapine response.
    Birkett, JTP
    Arranz, MJ
    Kirov, G
    Munro, J
    Murray, RM
    Collier, DA
    Kerwin, RW
    MOLECULAR PSYCHIATRY, 1999, 4 : S88 - S88
  • [45] Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia
    Yamazaki, Mayako
    Yamamoto, Noriyuki
    Yarimizu, Junko
    Okabe, Mayuko
    Moriyama, Ai
    Furutani, Masako
    Marcus, Monica M.
    Svensson, Torgny H.
    Harada, Katsuya
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (05) : 620 - 629
  • [46] The 5-HT5A Receptor Regulates Excitability in the Auditory Startle Circuit: Functional Implications for Sensorimotor Gating
    Curtin, Paul C. P.
    Medan, Violeta
    Neumeister, Heike
    Bronson, Daniel R.
    Preuss, Thomas
    JOURNAL OF NEUROSCIENCE, 2013, 33 (24): : 10011 - +
  • [47] Genetic variation of 5-HT5A receptor does not increase the risk for major affective disorders.
    Arias, B
    Collier, D
    Gutiérrez, B
    Pintor, L
    Gastó, C
    Martín, B
    Fañanás, L
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 497 - 497
  • [48] Inactive 5-HT7 Receptors Associate with Inactive and Active Gs Heterotrimers
    Jang, Wonjo
    Lambert, Nevin
    FASEB JOURNAL, 2020, 34
  • [49] Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: Interaction studies with citalopram
    Gannon, Robert L.
    Peglion, Jean-Louis
    Milian, Mark J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (12) : 887 - 897
  • [50] Human 5-HT5A receptor gene: Systematic screening for DNA sequence variation and linkage mapping on chromosome 7434-q36.
    Vogt, IR
    ShimronAbarbanell, D
    Erdmann, J
    Bryan, SP
    Spurr, NK
    Knapp, M
    Propping, P
    Nothen, MM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06): : 619 - 619